BSECompany Update25 Aug 2026 · 25 Aug 2026, 08:09 pm
Allotment of 19,100 Equity Shares pursuant to exercise of ESOPs under Emcure - Employee Stock Option Scheme 2013
Emcure Pharmaceuticals Ltd · 544210
✦ AI SummaryBonus/Split
Emcure Pharmaceuticals Ltd has allotted 19,100 equity shares to eligible employees under the Emcure - Employee Stock Option Scheme 2013, increasing the issued and paid-up share capital to Rs.1,89,69,92,470.
Analysis Scores
Earnings Impact1/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Attachments (1)
📄pdf
Download →
6d5dbb3c-b68d-4a97-b20f-a48f953c6197.pdf
View document text
Emcure
Ref: EPL/CS/SE/0074/2026 Date: August 25, 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, C-1, Block G, P J Towers,
Bandra Kurla Complex, Bandra (East), Dalal Street,
Mumbai – 400 051 Mumbai- 400 001
Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE
Dear Sir/Madam,
Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 - Allotment of Equity Shares pursuant to exercise of ESOPs under the
Emcure - Employee Stock Option Scheme 2013.
Pursuant to Regulation 30 read with Schedule III to the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we hereby inform that the Nomination and
Remuneration Committee of the Board of Directors of the Company, vide its Resolution by Circulation
(No. 03 of 2026-27) passed on August 25, 2026, has approved allotment of 19,100 (Nineteen Thousand One
Hundred) Equity Shares of Rs. 10/- (Rupees Ten only) each of the Company to the eligible employees,
pursuant to Emcure - Employee Stock Option Scheme 2013 (“Emcure ESOS 2013”), upon exercise of 19,100
vested options.
Further, consequent to the aforesaid allotment, the issued and paid-up share capital of the Company stands
increased as under:
From To
18,96,80,147 Equity Shares of Rs. 10/- each 18,96,99,247 Equity Shares of Rs. 10/- each
aggregating to Rs.1,89,68,01,470/- aggregating to Rs.1,89,69,92,470/-
The aforesaid Equity Shares shall rank pari passu in all aspects with the existing Equity Shares of the
Company.
You are requested to take the above information on your records.
Thanking you,
For Emcure Pharmaceuticals Limited
Amruta Yangalwar
Company Secretary and Compliance Officer
Membership No.: A25687
Emcure Pharmaceuticals Limited
Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India
Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060
E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251